Posterior Reversible Encephalopathy Syndrome (PRES) in Multiple Myeloma

Journal of Case Reports

article

Gianfranco Lapietra¹  Francesca Fazio¹  Federico Vozella¹  Francesca Maria Pirolli²  Maria Teresa Petrucci¹ 

[1] Department of Hematology, Department of Translational and Precision Medicine, Sapienza University;Department of Emergency Radiology, Sapienza University

关键词: Headache;    Hematologic Neoplasms;    Monoclonal Antibodies;    Multiple Myeloma;    Seizures.;   

DOI  :  10.17659/01.2020.0053

学科分类：生理学

来源: Journal of Case Reports

【 摘 要 】

Background: Multiple myeloma (MM) is a common hematologic malignancy. Immunomodulants, inhibitors of proteasome and monoclonal antibodies represent the standard of care regimens. Neurologic complications could occur in MM patients, both related to the disease or to the therapy. Posterior reversible encephalopathy syndrome (PRES) is a rare disease occurring with a several neurologic symptoms (seizures, headaches, visual loss and confusions) and characterized by typical imaging. It has been described in patients affected by malignancies but only few cases have been reported in MM patients on treatment. Case Report: We herein report the case of a 71 year-old woman with relapsed-refractory micro-molecular MM on treatment with immunomodulants who developed a clonic-tonic seizure during hospitalization for acute kidney failure. The brain computed-tomography (CT) scan and the magnetic resonance imaging (MRI), performed after the event, showed pathologic variations of cortical and subcortical signal of posterior cerebral regions. These findings were considered to be consistent with PRES. The cerebral lesions gradually disappeared, due to supportive therapy. The patient died to hematologic disease progression few months later. Conclusion: The pathophysiology of PRES is still unclear. Further studies are warranted to better understand its relation with multiple myeloma on treatment.

【 授权许可】

Unknown